Takeda drug impresses in ulcerative colitis study
(Reuters) - More than 40 percent of patients with moderate to severe ulcerative colitis achieved clinical remission from the debilitating condition after a year of taking an experimental drug developed by Japan's Takeda Pharmaceutical Co, according to data from a pivotal late-stage trial. (Source: Reuters: Health)

Thousands Of Genes Influenced By RNA Modification
A new discovery by researchers at Weill Cornell Medical College published in the May 17 edition of the journal Cell once again rewrites scientific textbooks. Only 10 years ago, epigenetic researchers had to abandon the long-held belief that DNA consists of just four bases when they discovered that chemically modified bases are, in fact, abundant components of the human genome... (Source: Health News from Medical News Today)